Business Context and Reporting Period
Company: Inmune Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 20, 2021
Reporting Period: Specific event date (September 20, 2021)
Business Context: The filing announces upcoming investor conference presentations by Raymond J. Tesi, MD, President and CEO. The company is an emerging growth company incorporated in Nevada.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a current report regarding corporate events rather than a periodic financial report.
Material Changes
No material financial changes or operational updates are reported in this filing. The sole material event is the scheduling of management participation in external investor conferences.
Guidance, Outlook, and Management Commentary
- Upcoming Events:
- Oppenheimer Fall Healthcare Life Sciences & MedTech Summit: Wednesday, September 22, 2021, at 1:15 PM ET.
- Cantor Fitzgerald Global Healthcare Conference: Wednesday, September 29, 2021, at 3:20 PM ET.
- Management Commentary: The filing references a press release (Exhibit 99.1) containing the official announcement but does not include specific commentary, guidance, or risk factors within the text of the 8-K itself.
Investor Verification Checklist
- Verify the content of the press release filed as Exhibit 99.1 for detailed commentary.
- Confirm the availability of the live or archived webcasts for the September 22 and September 29 conferences.
- Review the most recent 10-Q or 10-K filings for actual financial performance data, as this 8-K contains none.